Evaluation of the recombinant proteins RlpB and VacJ as a vaccine for protection against Glaesserella parasuis in pigs.
Animals
Antibodies, Bacterial
/ blood
Bacterial Proteins
/ immunology
Bacterial Vaccines
/ immunology
Haemophilus Infections
/ immunology
Haemophilus Vaccines
/ immunology
Haemophilus parasuis
/ genetics
Recombinant Proteins
/ immunology
Serogroup
Sus scrofa
Swine
Swine Diseases
/ immunology
Tissue Culture Techniques
/ veterinary
Vaccination
/ veterinary
Vaccines, Subunit
/ administration & dosage
Glaesserella parasuis
Glässer’s disease
Subunit vaccine
Journal
BMC veterinary research
ISSN: 1746-6148
Titre abrégé: BMC Vet Res
Pays: England
ID NLM: 101249759
Informations de publication
Date de publication:
27 May 2020
27 May 2020
Historique:
received:
26
11
2019
accepted:
14
05
2020
entrez:
29
5
2020
pubmed:
29
5
2020
medline:
5
1
2021
Statut:
epublish
Résumé
Glaesserella parasuis, the causative agent of Glӓsser's disease, is widespread in swine globally resulting in significant economic losses to the swine industry. Prevention of Glӓsser's disease in pigs has been plagued with an inability to design broadly protective vaccines, as many bacterin based platforms generate serovar or strain specific immunity. Subunit vaccines are of interest to provide protective immunity to multiple strains of G. parasuis. Selected proteins for subunit vaccination should be widespread, highly conserved, and surface exposed. Two candidate proteins for subunit vaccination (RlpB and VacJ) against G. parasuis were identified using random mutagenesis and an in vitro organ culture system. Pigs were vaccinated with recombinant RlpB and VacJ, outer membrane proteins with important contributions to cellular function and viability. Though high antibody titers to the recombinant proteins and increased interferon-γ producing cells were found in subunit vaccinated animals, the pigs were not protected from developing systemic disease. It appears there may be insufficient RlpB and VacJ exposed on the bacterial surface for antibody to bind, preventing high RlpB and VacJ specific antibody titers from protecting animals from G. parasuis. Additionally, this work confirms the importance of utilizing the natural host species when assessing the efficacy of vaccine candidates.
Sections du résumé
BACKGROUND
BACKGROUND
Glaesserella parasuis, the causative agent of Glӓsser's disease, is widespread in swine globally resulting in significant economic losses to the swine industry. Prevention of Glӓsser's disease in pigs has been plagued with an inability to design broadly protective vaccines, as many bacterin based platforms generate serovar or strain specific immunity. Subunit vaccines are of interest to provide protective immunity to multiple strains of G. parasuis. Selected proteins for subunit vaccination should be widespread, highly conserved, and surface exposed.
RESULTS
RESULTS
Two candidate proteins for subunit vaccination (RlpB and VacJ) against G. parasuis were identified using random mutagenesis and an in vitro organ culture system. Pigs were vaccinated with recombinant RlpB and VacJ, outer membrane proteins with important contributions to cellular function and viability. Though high antibody titers to the recombinant proteins and increased interferon-γ producing cells were found in subunit vaccinated animals, the pigs were not protected from developing systemic disease.
CONCLUSIONS
CONCLUSIONS
It appears there may be insufficient RlpB and VacJ exposed on the bacterial surface for antibody to bind, preventing high RlpB and VacJ specific antibody titers from protecting animals from G. parasuis. Additionally, this work confirms the importance of utilizing the natural host species when assessing the efficacy of vaccine candidates.
Identifiants
pubmed: 32460764
doi: 10.1186/s12917-020-02377-5
pii: 10.1186/s12917-020-02377-5
pmc: PMC7252510
doi:
Substances chimiques
Antibodies, Bacterial
0
Bacterial Proteins
0
Bacterial Vaccines
0
Haemophilus Vaccines
0
Recombinant Proteins
0
Vaccines, Subunit
0
Types de publication
Evaluation Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
167Subventions
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/G019177/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/G020744/1, BB/G019177/1, BB/G019274/1 and BB/G018553/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/G020744/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/G019274/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/G018553/1
Pays : United Kingdom
Références
Vaccine. 2016 Apr 27;34(19):2251-8
pubmed: 26993332
Stand Genomic Sci. 2011 Oct 15;5(1):61-8
pubmed: 22180811
Vaccine. 2009 Aug 20;27(38):5271-7
pubmed: 19576561
PLoS One. 2017 Apr 27;12(4):e0176537
pubmed: 28448603
Gene. 2017 Mar 1;603:42-53
pubmed: 27988234
PLoS Pathog. 2011 Jan 06;7(1):e1001247
pubmed: 21253576
J Vet Med Sci. 2001 May;63(5):487-91
pubmed: 11411491
Can J Vet Res. 1991 Jan;55(1):33-6
pubmed: 1832078
Clin Vaccine Immunol. 2012 Nov;19(11):1722-9
pubmed: 22933397
Vet Immunol Immunopathol. 2016 Nov 1;180:53-58
pubmed: 27692096
Can J Vet Res. 1989 Oct;53(4):390-3
pubmed: 2531627
Mol Microbiol. 1994 Jan;11(1):31-41
pubmed: 8145644
Proc Natl Acad Sci U S A. 2006 Aug 1;103(31):11754-9
pubmed: 16861298
Clin Vaccine Immunol. 2013 Sep;20(9):1466-72
pubmed: 23885030
PLoS One. 2014 Aug 19;9(8):e103787
pubmed: 25137096
Infect Immun. 2018 Feb 20;86(3):
pubmed: 29203546
J Bacteriol. 2008 Jul;190(13):4460-9
pubmed: 18424520
Am J Vet Res. 2003 Apr;64(4):435-42
pubmed: 12693533
Vet Microbiol. 2016 Feb 1;183:1-8
pubmed: 26790928
J Bacteriol. 1987 Dec;169(12):5692-9
pubmed: 3316191
FEMS Microbiol Rev. 2014 Jul;38(4):660-97
pubmed: 24372337
PLoS One. 2016 Mar 01;11(3):e0149132
pubmed: 26930282
Aust Vet J. 2010 Jul;88(7):255-9
pubmed: 20579030
Vet Rec. 2002 Oct 26;151(17):502-5
pubmed: 12430998
Vaccine. 2015 Mar 30;33(14):1695-701
pubmed: 25704800
Can J Vet Res. 1991 Jan;55(1):37-41
pubmed: 1884282
BMC Genomics. 2014 Dec 24;15:1179
pubmed: 25539682
Sci Rep. 2018 May 9;8(1):7372
pubmed: 29743502
J Clin Microbiol. 1992 Apr;30(4):862-5
pubmed: 1572971